FOXO4 — 10mg

PRE-ORDER — PRICE COMING SOON

SENOLYTIC · ZOMBIE CELL ELIMINATION

A senolytic peptide that disrupts the interaction between FOXO4 and p53 in senescent cells — forcing these 'zombie cells' into apoptosis (programmed death). Senescent cells accumulate with age and drive chronic inflammation and tissue dysfunction. Key research benefits: selective elimination of senescent cells, reduction of the senescence-associated secretory phenotype (SASP), decreased chronic inflammation, improved tissue regeneration, and potential extension of healthspan in aging research.

Catalog sizes: 10mg

Research Use Only. This product is intended exclusively for in vitro laboratory research use. It is not for human or veterinary use, has not been evaluated by the FDA, and is not intended to diagnose, treat, cure, or prevent any disease or condition.